Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Healing lives through Spirituality- Nikita Pandey Lifestyle
  • How Safe Society is Empowering the Marginalised on the Streets English
  • Spacenet reports 486% surge on PAT year-on-year basis Finance
  • American Tech Company GotChosen App launched by Bollywood Actress Nupur Sanon in India Business
  • BNI Greater Surat Welcomes 70+ Cities to the Epicenter of Business Excellence Business
  • Team Computers on the Future of Marketing: When AI Runs the Campaign, What Is Left for Marketers? Lifestyle
  • Pallavi Jha, Chairperson & MD, Walchand PeopleFirst and Dale Carnegie India Finance
  • Innovative 280 4WD Lion Series Launched by Captain Tractors with 100+ Deliveries, Revolutionizing Farming Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • The Rising Need for Insurance in Gated Communities in India – Ethika Leads the Way Forward Business
  • CapitalNumbers Infotech Limited Announces H2 FY26 & FY26 Results Business
  • Acknowledging the Work of These Amazing Doctors on National Doctor’s Day 2022 Business
  • Trailblazers of 2025: Shaping the Future of Business & Creativity Business
  • TiE Rajasthan’s TiE U Program Empowers College Startups for Fourth Consecutive Year Business
  • 100% job ready program by Red cyber academy, get govt. Approved diploma in cyber security Business

Recent Posts

  • Patil Automation Board Approves Rs 96.38 Crore Preferential Fund Raise
  • A First in India: Dermatologist Dr. Jagdish Sakhiya Launches Exclusive Facial Kit Formulated for Indian Skin
  • Fredun Pharmaceuticals Ltd. Acquires , from Pharma Major USV & its subsidiary Wellbeing Nutrition
  • Thrill Hikers Reviews: How Shared Journeys Are Turning Strangers Into Lifelong Travel Stories
  • Niharica Raizada Debuts Raizada Entertainments at 83rd Venice Film Festival with Amos Gitai’s The Road to Jericho

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Growington Ventures India Ltd aims for a strong growth going forward Business
  • From Africa to Ahmedabad: 14-year-old girl stands tall again after robotic spine surgery at Stavya Spine Hospital Health
  • Pioneering Global Call to Action: Transversality Awards and Conclave National
  • How Automated SEO Tools and AI Blog Generator Tools Are Transforming Digital Content Technology
  • Shangar Decor Ltd’s Rs. 49.35 crore Rights closes on December 6 Business
  • “IVF is Not the Last Resort – Boost Your Fertility Naturally,” Says Holistic Wellness Expert Health
  • 19th Asian Business & Social Forum 2023 and Greatest Brands & Leaders 2022-23, Bangkok, Thailand Business
  • Jabraj Singh Explains How ‘Make in India’ Is Strengthening India’s Power Transmission Ecosystem Lifestyle

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme